Immediate Impact
42 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Works of Grace Cullen being referenced
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Grace Cullen | 9 | 70 | 52 | 163 | 82 | 17 | 291 | |
| Samreen Naz | 3 | 45 | 44 | 110 | 95 | 15 | 270 | |
| Jining Feng | 1 | 43 | 51 | 115 | 96 | 20 | 290 | |
| Jun Lin | 8 | 97 | 67 | 79 | 38 | 25 | 292 | |
| Navdeep Upile | 13 | 60 | 60 | 80 | 121 | 17 | 310 | |
| Olga L. Bohn | 27 | 75 | 78 | 135 | 84 | 17 | 336 | |
| Ofer Ben‐Itzhak | 9 | 75 | 67 | 99 | 109 | 19 | 302 | |
| Raymond King‐Yin Tsang | 4 | 111 | 59 | 101 | 83 | 17 | 313 | |
| T G Cooke | 2 | 95 | 45 | 128 | 87 | 20 | 330 | |
| H. F. Otto | 18 | 35 | 51 | 78 | 61 | 16 | 332 | |
| Ping Wang | 3 | 65 | 38 | 155 | 33 | 22 | 303 |
All Works
Login with ORCID to disown or claim papers
Loading papers...